Zacks.com on MSN3h
AZN Q4 Earnings Lag, Sales Beat, Stock Up on China Probe UpdateAstraZeneca’s AZN fourth-quarter 2024 core earnings of $1.05 per American depositary share (“ADS”) missed the Zacks Consensus ...
Experts at the 2025 Clinical Trial Supply Europe will explore supply chain challenges and the impact of AI on trials.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback